Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 15 Sep 2009 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Canara Robeco Consumption Fund |
|---|---|
| 15 Sep 2009 | ₹100.00 |
| 12 Feb 2011 | ₹125.67 |
| 12 Jul 2012 | ₹134.73 |
| 09 Dec 2013 | ₹157.01 |
| 08 May 2015 | ₹242.09 |
| 04 Oct 2016 | ₹295.32 |
| 04 Mar 2018 | ₹355.32 |
| 01 Aug 2019 | ₹366.97 |
| 28 Dec 2020 | ₹503.18 |
| 27 May 2022 | ₹615.72 |
| 25 Oct 2023 | ₹784.98 |
| 23 Mar 2025 | ₹1002.39 |
| 20 Aug 2026 | ₹1098.41 |
| Metric | Canara Robeco · Regular NAV ₹110.39 Very High risk ★★★☆☆ | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| -1.56% | +5.83% | |
| +12.12% | +15.63% | |
| +12.23% | +13.23% | |
| +14.47% | +13.85% | |
| +15.21% | +12.26% | |
| +10.66% | — | |
| +16.34% | +15.60% | |
| +16.65% | +14.52% | |
| +16.11% | +13.74% | |
| Risk | ||
| 14.07% | 15.62% | |
| 0.40 | 0.43 | |
| 0.55 | 0.59 | |
| -34.77% | -23.65% | |
| Nifty 500 | — | |
| +0.18% | +3.42% | |
| 1.00 | 0.95 | |
| 106.2% | 105.9% | |
| 110.1% | 93.6% | |
| 2.16% | 2.39% | |
| ₹1,887Cr | ₹1,161Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| 40% | 45% | |
| Shridatta Bhandwaldar | — | |
| 15 Sep 2009 | — | |
| 44 | — | |
| 44.2% | — | |
| 3.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.